• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HISTOSONICS, INC. EDISON SYSTEM; Focused ultrasound system for non-thermal, mechanical tissue ablation

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HISTOSONICS, INC. EDISON SYSTEM; Focused ultrasound system for non-thermal, mechanical tissue ablation Back to Search Results
Catalog Number EDNTC1001
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Adult Respiratory Distress Syndrome (1696); Cardiac Arrest (1762); Respiratory Acidosis (2482); Thrombosis/Thrombus (4440)
Date of Event 04/07/2025
Type of Reportable Event Death
Additional Manufacturer Narrative
No other device malfunctions or other noteworthy events occurred during the case.
 
Event or Problem Description
As part of the boombox post-market clinical trial, patient id (b)(6), died due to what the treating physician believes to be a thromboembolic event possibly related to the histotripsy device and histotripsy procedure performed on (b)(6) 2025.An 87 year old male patient with a history of sigmoid colon cancer, which had been resected 4 years prior, received histotripsy treatment on (b)(6) 2025 to 2 lesions in segments v (x=25 mm, y=30 mm, z = 30 mm, ptv = 29.3 cc) and vi (x=18 mm, y=22 mm, z = 14.5 mm, ptv = 11.5 cc) for a total planned treatment volume (ptv) 40.8 cc.Per the treating physician, no anti-coagulation therapy was provided prior to the histotripsy procedure.The patient had previously undergone sbrt in (b)(6) 2023, which potentially overlapped with the histotripsy ptvs.During the intraoperative course, two system errors occurred which required a system reset resulting in a cumulative delay of approximately 30 minutes.The total procedure time under anesthesia was approximately 3.5 hours.Per the treating physician, the patient's immediate post procedure recovery was uneventful.He exhibited normal neurological function, was alert, ambulating, and able to tolerate oral intake.He was transferred to the post-anesthesia care unit (pacu) in stable condition with plans for postoperative imaging, including a ct scan.While being transported for imaging, the patient suffered a cardiac arrest.Resuscitation efforts were extensive, involving 30 minutes of cardiopulmonary resuscitation (cpr) and the administration of thrombolytic therapy.Return of spontaneous circulation was achieved; however, the patient subsequently developed acute respiratory distress syndrome (ards).The patient then experienced refractory metabolic acidosis.Despite aggressive critical care interventions, the patient showed no signs of recovering, and following discussions with the family, life-sustaining treatments were withdrawn.The patient was pronounced deceased on (b)(6) 2025.A transthoracic echocardiogram performed during the resuscitation period demonstrated preserved cardiac function.No postoperative imaging was obtained.It was noted that the patient had no history of arrhythmia.For trial purposes, the event was classified by the treating physician as possibly related to the device and possibly related to the procedure.Per the treating physician, the most probable contributing factors were perioperative immobility and the absence of heparin prophylaxis.Given the patient's clinical course and known risks, this event was considered anticipated.This mdr is being submitted out of an abundance of caution due to the patient's death post-procedure although no definitive cause of death was determined.No other device malfunctions or other noteworthy events occurred during the case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDISON SYSTEM
Common Device Name
Focused ultrasound system for non-thermal, mechanical tissue ablation
Manufacturer (Section D)
HISTOSONICS, INC.
16305 36th ave n
suite 300
plymouth MN 55446
Manufacturer (Section G)
HISTOSONICS, INC.
16305 36th ave n
suite 300
plymouth MN 55446
Manufacturer Contact
leeanne swiridow
16305 36th ave n
suite 300
plymouth, MN 55446
6123510361
MDR Report Key21989353
Report Number3027664504-2025-00006
Device Sequence Number8030204
Product Code QGM
Combination Product (Y/N)N
Initial Reporter StateNV
Initial Reporter CountryUS
PMA/510(K) Number
K233466
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/08/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberEDNTC1001
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/08/2025
Initial Report FDA Received Date05/08/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/25/2024
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization; Death;
Patient Age87 YR
Patient SexMale
-
-